Eyegate Pharmaceuticals, Inc. (NASDAQ:EYEG) reported the earnings of $-0.36/Share in the last quarter where the estimated EPS by analysts was $-0.46/share. The difference between the expected and actual EPS was $0.1/share, which represents an Earnings surprise of 21.7%.
Some buy side analysts are also providing their Analysis on Eyegate Pharmaceuticals, Inc., where 0 analysts have rated the stock as Strong buy, 3 analysts have given a Buy signal, 0 said it’s a HOLD, 0 reported it as Underperform and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)
When it comes to the Analysis of a Stock, Price Target plays a vital role. 3 Analysts reported that the Price Target for Eyegate Pharmaceuticals, Inc. might touch $10 high while the Average Price Target and Low price Target is $8.67 and $6 respectively.
To analyze a stock, one should look for Upgrades and Downgrades of a stock. Eyegate Pharmaceuticals, Inc. got Initiated on 7-Apr-16 where investment firm Noble Financial Initiated the stock to Buy.
Eyegate Pharmaceuticals, Inc. closed its last trading session at $1.69 with the gain of 9.47%. The Market Capitalization of the company stands at 17.74 Million. The Company has 52-week high of $5.1 and 52-week low of $1.11. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is 24.22% where SMA50 and SMA200 are 16.99% and -26.32% respectively. The Company Touched its 52-Week High on Mar 2, 2016 and 52-Week Low on Nov 3, 2016.
The Relative Volume of the company is 14.11 and Average Volume (3 months) is 161.34 million. Eyegate Pharmaceuticals, Inc. P/E (price to earnings) ratio is 0 and Forward P/E ratio of 0.
The company shows its Return on Assets (ROA) value of -109.1%. The Return on Equity (ROE) value stands at -219.6%. While it’s Return on Investment (ROI) value is 0%.
While looking at the Stock’s Performance, Eyegate Pharmaceuticals, Inc. currently shows a Weekly Performance of 3.36%, where Monthly Performance is 23.33%, Quarterly performance is 5.71%, 6 Months performance is -46.22% and yearly performance percentage is -38.74%. Year to Date performance value (YTD perf) value is -32.48%. The Stock currently has a Weekly Volatility of 11.90% and Monthly Volatility of 14.16%.